Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
Modulation of Angiotensin II Type 1 Receptor mRNA Expression in Human Blood Cells
Comparison of Platelets and Mononuclear Leucocytes
HIROMICHI SUZUKIHIROTAKA SHIBATAMAROHITO MURAKAMIATSUHISA SATOMAREO NAITOATSUHIRO ICHIHARAAKIRA MATSUMOTOGOZOH TSUJIMOTOAKIRA HIRASAWAKUNIKO HORIETAKAO SARUTA
Author information
JOURNAL FREE ACCESS

1995 Volume 42 Issue 1 Pages 15-22

Details
Abstract

The objective of the present study was to quantify the expression of angiotensin II type 1 (AT1) receptor transcripts in human blood cells-platelets and mononuclear leucocytes-from 10 normal healthy volunteers during the alterations in the renin-angiotensin system. A quantitative assay employing reverse transcription-polymerase chain reaction (RT-PCR) was utilized. Oral administration of furosemide, 40mg for 2 days, under mild salt restriction (50mEq NaCl/day) for 6 days stimulated the rennin-angiotensin system resulting in significant increases in plasma renin activity (PRA) (1.84±0.12vs. 1.05± 0.17ng/l/s; P<0.01), plasma angiotensin II concentration, and plasma aldosterone concentration (PAC). The ratio of AT1 receptor mRNA to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA expression in mononuclear leucocytes was significantly (P<0.05) increased from the basal level (0.49±0.05 vs. 0.29±0.03) (P<0.01), while in platelets these changes were opposite (0.11±0.05vs. 0.25±0.05) (P<0.01). Compared to these significant changes, salt loading (200mEq NaCl/day) for 6 days decreased PRA(0.49±0.10vs. 1.05±0.17ng/l/s; P<0.01) and induced the opposite changes in the ratio of AT1 receptor/GAPDH mRNA. These data suggest that AT1 receptors in human blood cells may be of two different types-platelets and mononuclear leucocytes.

Content from these authors
© The Japan Endocrine Society
Previous article Next article
feedback
Top